Medicare Enrolled

Dr. Anand Kuruvilla, M.D.

Optician · Palatka, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
600 ZEAGLER DR, Palatka, FL 32177
3863258140
Registered in NPPES since 2006
NPI: 1740246974 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kuruvilla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kuruvilla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kuruvilla

Dr. Anand Kuruvilla is an optician specialist in Palatka, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kuruvilla performed 3,783 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kuruvilla received a total of $2,721 from 49 pharmaceutical and/or device companies across 135 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kuruvilla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 23% volume in FL $2,721 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 59637 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,783
Medicare services
Top 23% in FL for optician
Not available
Unique patients (not deduplicated)
$180
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
CT guidance for radiation therapy
This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery.
1,036 $94 $632
Intensity-modulated radiation therapy delivery
Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session.
971 $274 $2,437
Radiation therapy, 3+ areas, 6-10 MeV
Radiation treatment delivered to three or more separate areas using advanced techniques like custom blocking and rotational beams with an energy level of 6-10 MeV.
340 $179 $734
Continuing radiation therapy consultation per week
A weekly consultation to review and manage ongoing radiation therapy treatment.
290 $67 $422
Radiation treatment management, 5 sessions
Oversight and management of a radiation therapy course consisting of five treatment sessions.
277 $155 $1,023
Design and construction of complex radiation treatment device
This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated.
137 $97 $702
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
117 $69 $395
Calculation of radiation therapy dose 112 $52 $358
Complex radiation therapy planning 53 $108 $916
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $98 $430
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
46 $81 $588
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 44 $410 $2,456
Design and construction of radiation treatment device
This code covers the design and construction of a device used for high precision radiation therapy. It does not include the actual administration of radiation treatment.
43 $365 $2,722
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
42 $1,123 $15,457
X-ray during radiation therapy
An X-ray image taken while radiation therapy is being administered to verify treatment positioning.
40 $11 $58
High precision radiation therapy planning
This procedure involves the detailed planning and setup required for delivering high-precision radiation therapy to a target area of the body.
30 $1,420 $10,382
Radiation treatment planning, complex
This procedure involves obtaining the necessary data to develop an optimal radiation treatment plan for three or more treatment areas, or any number of areas requiring special treatment.
28 $340 $2,650
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
23 $132 $895
Radiation treatment planning, 1 area
This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area.
22 $208 $1,448
3D radiation therapy planning
This procedure involves creating a three-dimensional treatment plan for radiation therapy. It uses imaging data to map the target area and surrounding tissues to guide precise radiation delivery.
20 $376 $2,633
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $40 $235
Special radiation treatment 19 $111 $782
Injection of biodegradable material next to prostate
A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland.
11 $133 $7,712
Prostate radiation therapy device placement
A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment.
11 $41 $558
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,721
Total received (2018-2024)
Avg $389/year across 7 years
Top 32% in FL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
135
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$469
2023
$372
2022
$425
2021
$418
2020
$442
2019
$447
2018
$148

Payments by company (2024)

Daiichi Sankyo Inc.
$98
Astellas Pharma US Inc
$82
Eisai Inc.
$43
AstraZeneca Pharmaceuticals LP
$40
Aveo Pharmaceuticals, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$30
Janssen Biotech, Inc.
$26
Merck Sharp & Dohme LLC
$21
JAZZ PHARMACEUTICALS INC.
$18
Exelixis Inc.
$17
Novartis Pharmaceuticals Corporation
$17
TerSera Therapeutics LLC
$15
Myriad Genetic Laboratories, Inc.
$15
Lilly USA, LLC
$14
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
Seagen Inc.
$225
AstraZeneca Pharmaceuticals LP
$181
Lilly USA, LLC
$150
Varian Medical Systems, Inc.
$138
Foundation Medicine, Inc.
$138
Boston Scientific Corporation
$137
Eisai Inc.
$125
Daiichi Sankyo Inc.
$122
Astellas Pharma US Inc
$112
Merck Sharp & Dohme LLC
$85
Janssen Biotech, Inc.
$81
Amgen Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$78
GlaxoSmithKline, LLC.
$67
E.R. Squibb & Sons, L.L.C.
$56
Merck Sharp & Dohme Corporation
$56
Celgene Corporation
$55
JAZZ PHARMACEUTICALS INC.
$54
Dova Pharmaceuticals
$53
Focal Therapeutics, Inc.
$53
EISAI INC.
$50
Novartis Pharmaceuticals Corporation
$43
Regeneron Healthcare Solutions, Inc.
$40
TerSera Therapeutics LLC
$38
SANOFI-AVENTIS U.S. LLC
$35
Epizyme, Inc.,
$34
Global Blood Therapeutics, Inc.
$34
Aveo Pharmaceuticals, Inc.
$33
AMAG Pharmaceuticals, Inc.
$29
Karyopharm Therapeutics Inc.
$28
PFIZER INC.
$25
Ipsen Biopharmaceuticals, Inc
$24
PUMA BIOTECHNOLOGY, INC.
$23
GENZYME CORPORATION
$18
Exelixis Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$17
AbbVie Inc.
$17
ARRAY BIOPHARMA INC
$17
Taiho Oncology, Inc.
$16
Incyte Corporation
$16
ABBVIE INC.
$16
Servier Pharmaceuticals LLC
$16
Alexion Pharmaceuticals, Inc.
$15
AVEO Pharmaceuticals, Inc.
$15
Myriad Genetic Laboratories, Inc.
$15
Teva Pharmaceuticals USA, Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
CashFlow Solutions, LLC
$11
Top 3 companies account for 20.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · BENDEKA · BLENREP · BRAFTOVI · BioZorb · Blincyto · CABOMETYX · CALQUENCE · CYRAMZA · DARZALEX · Doptelet · ENHERTU · ERLEADA · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GENERAL THERAPIES · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · Kyprolis · LIBTAYO · LUTATHERA · Lenvima · Lonsurf · Lympha Press Optimal Plus(US) BT · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OPDIVO · OXBRYTA · PADCEV · PROLARIS · PROMACTA · Padcev · REBLOZYL · RETEVMO · SOMATULINE DEPOT · SPACEOAR · TAGRISSO · TAZVERIK · TIBSOVO · TIVDAK · TUKYSA · TrueBeam · ULTOMIRIS · VENCLEXTA · VERZENIO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in Palatka?
Compare opticians in the Palatka area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
27
County median income
$47,256
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA PUTNAM HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kuruvilla is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kuruvilla experienced with ct guidance for radiation therapy?
Based on Medicare claims data, Dr. Kuruvilla performed 1,036 ct guidance for radiation therapy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kuruvilla receive payments from pharmaceutical companies?
Yes. Dr. Kuruvilla received a total of $2,721 from 49 companies across 135 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kuruvilla's costs compare to other opticians in Palatka?
Dr. Kuruvilla's average Medicare payment per service is $180. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kuruvilla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →